Authors: Jansen S et al. Anesthesiology 144(4):913–925, April 2026 Summary:This randomized, double-blind, placebo-controlled study compares the respiratory and analgesic effects of Cebranopadol with Oxycodone in healthy volunteers. Cebranopadol is a novel analgesic that activates both nociceptin (NOP) and µ-opioid (MOP) receptors, raising the possibility of effective pain control with less respiratory depression than traditional opioids. […]
Read MoreIf you are having problems staffing or managing your anesthesia department, you are not alone. Hospitals and surgery centers across the country are facing the same challenges—and they are getting worse, not better. The reality is simple: anesthesia coverage has become a make-or-break issue for operating room efficiency, surgeon satisfaction, and ultimately hospital revenue. When […]
Read MoreBurnout or time away in pain, ICU, or administration doesn’t erase your anesthesia training—it just requires a structured path back. For many physicians, it simply means you stepped away to regroup. We work with anesthesiologists every day who want to return to clinical anesthesia after time away in: administration or leadership roles pain medicine critical […]
Read MoreHardin Medical Center (122 beds) is offering a rare CRNA-only practice where you can enjoy full autonomy and an exceptional lifestyle. • Schedule: 2 weeks on / 1 week off (17 weeks off each year)• Model: Independent CRNA practice – no anesthesiologist supervision• Case Mix: General surgery, orthopedics, endoscopy, OB/GYN (including epidurals & C-sections)• No […]
Read MoreAuthors: Wang T et al. Anesthesiology 144(4):837–852, April 2026 Summary:This prospective study explores whether electroencephalogram (EEG) patterns—specifically phase–amplitude coupling (PAC)—can serve as a real-time marker of nociception and analgesic effectiveness during surgery. Traditional intraoperative monitoring of pain relies largely on indirect signs such as hemodynamics, but EEG-based measures may offer a more direct window into […]
Read More